BCM
IONS icon

Bridgeway Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bridgeway Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-36,000
Closed -$2.12M – 1339
2020
Q2 		$2.12M Sell
36,000
-200
-0.6% -$11.1K 0.04% 395
2020
Q1 		$1.71M Hold
36,200
– – 0.04% 386
2019
Q4 		$2.19M Hold
36,200
– – 0.03% 507
2019
Q3 		$2.17M Buy
+36,200
New +$2.36M 0.03% 480
2017
Q3 		– Sell
-59,800
Closed -$3.04M – 1426
2017
Q2 		$3.04M Sell
59,800
-41,900
-41% -$1.95M 0.04% 410
2017
Q1 		$4.09M Sell
101,700
-58,800
-37% -$2.64M 0.05% 316
2016
Q4 		$7.68M Buy
+160,500
New +$6.35M 0.1% 174

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bridgeway Capital Management's IONS Position: Q3 2020 in Review

Bridgeway Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2020, closing a stake of 36,000 shares — an estimated $2.12M sold.

Bridgeway Capital Management first reported a position in IONS in Q4 2016 and held it in 7 quarters. The position peaked at $7.68M in Q4 2016. 367 funds tracked by Wall St. Rank hold IONS as of Q3 2020.

  • Bridgeway Capital Management reported no remaining Ionis Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Bridgeway Capital Management sold 36,000 Ionis Pharmaceuticals shares in Q3 2020, an estimated $2.12M.
  • Bridgeway Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2016 and held it in 7 quarters.
  • Bridgeway Capital Management's Ionis Pharmaceuticals position peaked at $7.68M in Q4 2016.
  • 367 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2020.

Based on Bridgeway Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.